Cohance Lifesciences Limited
NSE: COHANCE | Information Technology
Market Fundamentals
Stock Intelligence & News
Cohance Lifesciences Limited
Cohance Lifesciences Limited has informed the Exchange about Transcript |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
Read Full Analysis →Cohance Lifesciences Limited
Cohance Lifesciences Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
Read Full Analysis →Cohance Lifesciences Limited
Cohance Lifesciences Limited has informed the Exchange about Copy of Newspaper Publication |SUBJECT: Copy of Newspaper Publication
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Cohance Q4 Profit Slumps 72%, ICICI Securities Downgrades to Reduce'
While Cohance continues to have a strong near-term pipeline of four late-stage phase3 projects, commercialisation timelines for these remain uncertain.
Read Full Analysis →Cohance Lifesciences shares slip 7% after Jefferies cuts target price, downgrades on weak Q4
Cohance Lifesciences shares dropped significantly after reporting an 84% year-on-year decline in March-quarter net profit. Jefferies downgraded the stock to "Underperform" citing management instability and weak visibility, while Goldman Sachs maintained its "Buy" rating, seeing long-term opportunities despite a challenging near-term outlook.
Read Full Analysis →Jefferies Downgrades A Stock That Has Gained 33% In Three Weeks
The brokerage cuts Cohance Life to Underperform, citing weak fundamentals that it says the recent rally hasn't priced in.
Read Full Analysis →Cohance Lifesciences Limited
Cohance Lifesciences Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
Read Full Analysis →Cohance Lifesciences Limited
Cohance Lifesciences Limited has informed the Exchange about Board Meeting to be held on 12-May-2026 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2026 . |SUBJECT: Board Meeting Intimation
Read Full Analysis →Cohance Lifesciences Limited
Financial Results |Meeting Date: 12-May-2026
Read Full Analysis →F&O Talk: Nifty charts suggest further consolidation; Sudeep Shah's strategy on Cohance, HEG and 4 more stocks
Indian markets corrected amid volatility, with Nifty entering a consolidation phase after a sharp April rally. Technical indicators suggest a range-bound trend with key support and resistance levels in focus. Weakness in banking stocks persists, while smallcaps continue to outperform, offering selective opportunities for investors in the near term.
Read Full Analysis →Get instant alerts when COHANCE breaks news
Join investors who track Cohance Lifesciences Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for COHANCE?
COHANCE is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Cohance Lifesciences Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding COHANCE to your custom watchlist.